Isolation of a proteinase with plasminogen-activating activity from Lachesis muta muta (bushmaster) snake venom.
A plasminogen activator enzyme (LV-PA) from Lachesis muta muta venom was purified to homogeneity using gel filtration and anion exchange chromatography. SDS-PAGE under reducing conditions showed a single protein band with an Mr of 33,000 Da. It is an acidic glycoprotein which activates plasminogen to plasmin indirectly, functioning via prior formation of a molecular complex, known as plasminogen activator. The purified preparation catalyzes the hydrolysis of several p-nitroanilide peptide substrates containing Lys at the scissile bond. In contrast, no hydrolysis was detected on the synthetic substrates TAME and BAPNA, which contain arginine. By the use of the plasmin-specific chromogenic substrate Tos-Gly-Pro-Lys-pNA, the preparation had a plasmin-like activity of 0.68 U/mg, which was 35.8-fold higher than that of the crude venom from which it was prepared. In vitro, fibrin hydrolysis using LV-PA as plasminogen activator displayed more similarity with the effect produced by streptokinase (SK). SDS-PAGE (10%) analysis showed a 115-kDa complex formation after incubation of plasminogen with either LV-PA or SK. At a molar ratio of 50:1 (fibrinogen:enzyme), the preparation exhibited weakly fibrinogenolytic activity. However, LV-PA is distinguished from thrombin in that it does not clot fibrinogen. After incubation of LV-PA with platelet-rich plasma, the enzyme (2 microM) showed no effect on platelet aggregation induced by ADP, epinephrine, or collagen. Comparison of the N-terminal sequence of LV-PA with other snake venom plasminogen activators revealed that LV-PA exhibits a high degree of sequence identity with the TsVPA from Trimeresurus stejnegeri (90%) and with the Haly-PA from Agkistrodon halys (85%). LV-PA also has homology with other snake venom serine proteinases such as the thrombin-like/gyroxin analogue (38%) from bushmaster venom and with other coagulation serine proteases. The proteinase was readily inhibited by treatment with p-nitrophenyl p-guanidinebenzoate, p-aminobenzamidine, and phenylmethanesulfonyl fluoride but was not affected by metal chelators.
Sanchez
E F
EF
Centro de Pesquisa e Desenvolvimento, Fundacão Ezequiel Dias, Belo Horizonte, MG, Brazil. eladio@funed.mg.gov.br
Santos
C I
CI
Magalhaes
A
A
Diniz
C R
CR
Figueiredo
S
S
Gilroy
J
J
Richardson
M
M
D000595:Amino Acid Sequence; D000818:Animals; D002364:Caseins / Q000378:metabolism; D010450:Endopeptidases / Q000235:genetics / Q000302:isolation & purification* / Q000494:pharmacology; D005342:Fibrinolysis / Q000187:drug effects; D006801:Humans; D066298:In Vitro Techniques; D008969:Molecular Sequence Data; D008970:Molecular Weight; D010960:Plasminogen Activators / Q000235:genetics / Q000302:isolation & purification* / Q000494:pharmacology; D010974:Platelet Aggregation / Q000187:drug effects; D017386:Sequence Homology, Amino Acid; D013379:Substrate Specificity; D014757:Viper Venoms / Q000737:chemistry / Q000201:enzymology* / Q000235:genetics; D017819:Viperidae / Q000235:genetics / Q000378:metabolism*
D002364:Caseins; C002087:N,N-dimethylcasein; D014757:Viper Venoms; D010450:Endopeptidases; D010960:Plasminogen Activators